I Venturo < I Virgolini < I Visoly-Fisher

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
003693 (2002)		Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
003814 (2002)		Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
003842 (2001)		Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
003850 (2001)		Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells.
003936 (2001)		111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
003958 (2001)		New trends in peptide receptor radioligands.
003A83 (2001)		Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells.
003C26 (2000)		New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
003C83 (2000)		An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: usefulness of hepatobiliary imaging for differential diagnosis.
003D25 (2000)		Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.
003D67 (1999)		"MAURITIUS": tumour dose in patients with advanced carcinoma.
003E05 (1999)		DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
003F97 (1998)		Response to treatment with yttrium 90-DOTA-lanreotide of a patient with metastatic gastrinoma.
004016 (1998)		Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
004018 (1998)		Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
004063 (1998)		Location of a VIPoma by iodine-123-vasoactive intestinal peptide scintigraphy.
004075 (1998)		Visualization of intestinal splenosis by somatostatin receptor scintigraphy.
004267 (1997)		Radiation doses deriving from patients undergoing 111In-DTPA-D-phe-1-octreotide scintigraphy.
004343 (1997)		Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
004532 (1996)		In vitro and in vivo studies of three radiolabelled somatostatin analogues: 123I-octreotide (OCT), 123I-Tyr-3-OCT and 111In-DTPA-D-Phe-1-OCT.
004575 (1996)		Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i -k "I Virgolini" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/Author.i  \
                -Sk "I Virgolini" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    Author.i
   |clé=    I Virgolini
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024